SR ONE CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | DSGN | 6.53M | $49.14M |
 | ZBIO | 4.91M | $109.04M |
 | ORIC | 4.51M | $54.18M |
 | SPRY | 4.01M | $40.33M |
 | NKTX | 3.33M | $6.90M |
 | ACLX | 2.35M | $192.66M |
 | MLYS | 2.11M | $80.16M |
 | CRSP | 2.04M | $132.13M |
 | ALMS | 1.96M | $7.82M |
 | ENGN | 748K | $5.11M |
 | ORKA | 430K | $8.28M |
Design Therapeutics, Inc.
DSGN
Shares Held
6.53M
Value
$49.14M
Zenas BioPharma, Inc.
ZBIO
Shares Held
4.91M
Value
$109.04M
ORIC Pharmaceuticals, Inc.
ORIC
Shares Held
4.51M
Value
$54.18M
ARS Pharmaceuticals, Inc.
SPRY
Shares Held
4.01M
Value
$40.33M
Nkarta, Inc.
NKTX
Shares Held
3.33M
Value
$6.90M
Arcellx, Inc.
ACLX
Shares Held
2.35M
Value
$192.66M
Mineralys Therapeutics, Inc.
MLYS
Shares Held
2.11M
Value
$80.16M
CRISPR Therapeutics AG
CRSP
Shares Held
2.04M
Value
$132.13M
Alumis Inc. Common Stock
ALMS
Shares Held
1.96M
Value
$7.82M
enGene Holdings Inc.
ENGN
Shares Held
748K
Value
$5.11M
Oruka Therapeutics, Inc.
ORKA
Shares Held
430K
Value
$8.28M